º¬Ðß²ÝÊÓÆµ

+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Peptide Therapeutics Market 2024-2028 - Product Thumbnail Image

Peptide Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 148 Pages
  • Global
From
From
GLP-1 Receptor Agonist - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Receptor Agonist - Global Strategic Business Report

  • Report
  • July 2026
  • 483 Pages
  • Global
From
From
From
From
From
From
Clinical Trials Market in the US 2026-2030 - Product Thumbnail Image

Clinical Trials Market in the US 2026-2030

  • Report
  • April 2026
  • 195 Pages
  • United States
From
From
Chronic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Kidney Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Phenylbutazone API Market - Global Forecast to 2030 - Product Thumbnail Image

Phenylbutazone API Market - Global Forecast to 2030

  • Report
  • August 2025
  • 191 Pages
  • Global
From
From
From
Loading Indicator